Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a single X-Ray predict lung biopsy safety and speed up discharge?

NCT ID NCT06563167

Diagnosis Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This study tests whether a chest X-ray taken 4 hours after a lung biopsy can predict if a patient will develop a serious complication called pneumothorax (collapsed lung) later. Researchers will compare X-rays taken at different times to see if a clear X-ray at 4 hours means the patient is safe to go home the same day. The study involves 330 patients undergoing image-guided lung biopsies in Hong Kong.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Chest X-ray (CXR) at multiple time points after lung biopsy
What this could lead to
If a clear X-ray at 4 hours reliably rules out later complications, many patients could safely go home the same day after a lung biopsy.
What could go wrong
This is a single-center study, and the X-ray's accuracy may vary in broader populations. A negative early X-ray does not guarantee no delayed complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 330 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who will require image-guided TTLB

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients whose image-guided TTLB, including ultrasound or CT-guided, is arranged for diagnostic purposes * Patients who are able to sign written informed consent to participate in the study Exclusion Criteria: * Patients with resolution of lung lesion prior to the scheduled image-guided TTLB * Patients have active exacerbation of underlying diseases causing unstable respiratory conditions (e.g. exacerbation of COPD, pneumonia) which would lower the threshold for invasive interventions for iatrogenic pneumothorax * Patients with psychiatric disease or cognitive impairment that may limit their ability to understand or give consent to the study * Patients who decline to join the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung biopsy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung biopsy

Contacts and locations

Locations

  • Chinese University of Hong Kong

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.